Synthesis and Biological Evaluation of Amino Chalcone Derivatives as Antiproliferative Agents. 2020

Chao-Fan Lu, and Sheng-Hui Wang, and Xiao-Jing Pang, and Ting Zhu, and Hong-Li Li, and Qing-Rong Li, and Qian-Yu Li, and Yu-Fan Gu, and Zhao-Yang Mu, and Min-Jie Jin, and Yin-Ru Li, and Yang-Yang Hu, and Yan-Bing Zhang, and Jian Song, and Sai-Yang Zhang
Department of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450001, China.

Chalcone is a common scaffold found in many biologically active compounds. The chalcone scaffold was also frequently utilized to design novel anticancer agents with potent biological efficacy. Aiming to continue the research of effective chalcone derivatives to treat cancers with potent anticancer activity, fourteen amino chalcone derivatives were designed and synthesized. The antiproliferative activity of amino chalcone derivatives was studied in vitro and 5-Fu as a control group. Some of the compounds showed moderate to good activity against three human cancer cells (MGC-803, HCT-116 and MCF-7 cells) and compound 13e displayed the best antiproliferative activity against MGC-803 cells, HCT-116 cells and MCF-7 cells with IC50 values of 1.52 μM (MGC-803), 1.83 μM (HCT-116) and 2.54 μM (MCF-7), respectively which was more potent than the positive control (5-Fu). Further mechanism studies were explored. The results of cell colony formatting assay suggested compound 10e inhibited the colony formation of MGC-803 cells. DAPI fluorescent staining and flow cytometry assay showed compound 13e induced MGC-803 cells apoptosis. Western blotting experiment indicated compound 13e induced cell apoptosis via the extrinsic/intrinsic apoptosis pathway in MGC-803 cells. Therefore, compound 13e might be a valuable lead compound as antiproliferative agents and amino chalcone derivatives worth further effort to improve amino chalcone derivatives' potency.

UI MeSH Term Description Entries
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002599 Chalcone An aromatic KETONE that forms the core molecule of CHALCONES. Benzalacetophenone,Benzylideneacetophenone,1,3-Diphenyl-2-Propen-1-One,Chalkone,1,3 Diphenyl 2 Propen 1 One
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular

Related Publications

Chao-Fan Lu, and Sheng-Hui Wang, and Xiao-Jing Pang, and Ting Zhu, and Hong-Li Li, and Qing-Rong Li, and Qian-Yu Li, and Yu-Fan Gu, and Zhao-Yang Mu, and Min-Jie Jin, and Yin-Ru Li, and Yang-Yang Hu, and Yan-Bing Zhang, and Jian Song, and Sai-Yang Zhang
January 2018, Anti-cancer agents in medicinal chemistry,
Chao-Fan Lu, and Sheng-Hui Wang, and Xiao-Jing Pang, and Ting Zhu, and Hong-Li Li, and Qing-Rong Li, and Qian-Yu Li, and Yu-Fan Gu, and Zhao-Yang Mu, and Min-Jie Jin, and Yin-Ru Li, and Yang-Yang Hu, and Yan-Bing Zhang, and Jian Song, and Sai-Yang Zhang
September 2010, European journal of medicinal chemistry,
Chao-Fan Lu, and Sheng-Hui Wang, and Xiao-Jing Pang, and Ting Zhu, and Hong-Li Li, and Qing-Rong Li, and Qian-Yu Li, and Yu-Fan Gu, and Zhao-Yang Mu, and Min-Jie Jin, and Yin-Ru Li, and Yang-Yang Hu, and Yan-Bing Zhang, and Jian Song, and Sai-Yang Zhang
May 2012, Bioorganic & medicinal chemistry,
Chao-Fan Lu, and Sheng-Hui Wang, and Xiao-Jing Pang, and Ting Zhu, and Hong-Li Li, and Qing-Rong Li, and Qian-Yu Li, and Yu-Fan Gu, and Zhao-Yang Mu, and Min-Jie Jin, and Yin-Ru Li, and Yang-Yang Hu, and Yan-Bing Zhang, and Jian Song, and Sai-Yang Zhang
February 2024, International journal of molecular sciences,
Chao-Fan Lu, and Sheng-Hui Wang, and Xiao-Jing Pang, and Ting Zhu, and Hong-Li Li, and Qing-Rong Li, and Qian-Yu Li, and Yu-Fan Gu, and Zhao-Yang Mu, and Min-Jie Jin, and Yin-Ru Li, and Yang-Yang Hu, and Yan-Bing Zhang, and Jian Song, and Sai-Yang Zhang
September 2013, Molecules (Basel, Switzerland),
Chao-Fan Lu, and Sheng-Hui Wang, and Xiao-Jing Pang, and Ting Zhu, and Hong-Li Li, and Qing-Rong Li, and Qian-Yu Li, and Yu-Fan Gu, and Zhao-Yang Mu, and Min-Jie Jin, and Yin-Ru Li, and Yang-Yang Hu, and Yan-Bing Zhang, and Jian Song, and Sai-Yang Zhang
May 2012, Bioorganic & medicinal chemistry letters,
Chao-Fan Lu, and Sheng-Hui Wang, and Xiao-Jing Pang, and Ting Zhu, and Hong-Li Li, and Qing-Rong Li, and Qian-Yu Li, and Yu-Fan Gu, and Zhao-Yang Mu, and Min-Jie Jin, and Yin-Ru Li, and Yang-Yang Hu, and Yan-Bing Zhang, and Jian Song, and Sai-Yang Zhang
January 2023, Current drug discovery technologies,
Chao-Fan Lu, and Sheng-Hui Wang, and Xiao-Jing Pang, and Ting Zhu, and Hong-Li Li, and Qing-Rong Li, and Qian-Yu Li, and Yu-Fan Gu, and Zhao-Yang Mu, and Min-Jie Jin, and Yin-Ru Li, and Yang-Yang Hu, and Yan-Bing Zhang, and Jian Song, and Sai-Yang Zhang
September 2016, Steroids,
Chao-Fan Lu, and Sheng-Hui Wang, and Xiao-Jing Pang, and Ting Zhu, and Hong-Li Li, and Qing-Rong Li, and Qian-Yu Li, and Yu-Fan Gu, and Zhao-Yang Mu, and Min-Jie Jin, and Yin-Ru Li, and Yang-Yang Hu, and Yan-Bing Zhang, and Jian Song, and Sai-Yang Zhang
September 2011, European journal of medicinal chemistry,
Chao-Fan Lu, and Sheng-Hui Wang, and Xiao-Jing Pang, and Ting Zhu, and Hong-Li Li, and Qing-Rong Li, and Qian-Yu Li, and Yu-Fan Gu, and Zhao-Yang Mu, and Min-Jie Jin, and Yin-Ru Li, and Yang-Yang Hu, and Yan-Bing Zhang, and Jian Song, and Sai-Yang Zhang
July 2019, European journal of medicinal chemistry,
Copied contents to your clipboard!